Hematology, Oncology, and Blood and Marrow Transplant
Nationally ranked by U.S. News & World Report
Hematology, Oncology, and Blood and Marrow Transplant
Nationally ranked by U.S. News & World Report
The Division of Pediatric Hematology, Oncology and Blood and Marrow Transplantation provides comprehensive care for nearly 2,000 children and families each year. As a U.S. News and World Report top-rated hospital, Children’s Mercy is focused on research that produces real results—like survival rates that beat the national average—for children with cancer, sickle cell disease, hemophilia and other blood disorders.
Meet our expert care team
All the programs in our Hematology, Oncology and Blood and Marrow Transplant division take a team approach to care. That means you’ll have a specific doctor, advanced practice provider, and social worker who will care for your child every time you come to the clinic.
With more than 25 pediatric hematology and oncology doctors on staff, you will be matched with someone who is knowledgeable and experienced in your child’s particular condition.
Your Children’s Mercy team will partner with your child’s primary care provider, school and other caregivers, no matter where you live, to ensure your child is receiving the care they need to get better.
Research partnerships
Kansas City is a growing hub for life sciences research, attracting top scientists from around the world. Children’s Mercy participates in national research collaboratives such as the Children’s Oncology Group.
Our physicians and scientists are also collaborating with local institutions such as the University of Kansas Cancer Center and the Stowers Institute for Medical Research to improve understanding, diagnosis and treatment of pediatric cancer and blood disorders.
Because of these partnerships and the ongoing research happening at Children’s Mercy each day, we are moving closer to our goal of finding effective treatments for every child.
“To achieve advances in therapy, it’s critical to combine forces.”
Family centered care
When your child is diagnosed with cancer or a blood disorder, it affects your entire family. We are committed to providing not only excellent medical care, but comprehensive support for your family throughout your time with us.
Children’s Mercy has a dedicated Family Care Team just for children and families who are receiving treatment for a hematology or oncology diagnosis. They bring together social, emotional and spiritual wellness resources to help you navigate life in the hospital and beyond.
Mentoring programs for parents and teens match experienced families with those who are new to their diagnosis or would like extra support from someone who understands what it’s like to undergo treatment.
See how we will support your entire familyClinical Services
The Hematology Department cares for children with sickle cell disease, hemophilia, and all types of bleeding disorders. Children’s Mercy is a federally-designated Hemophilia Treatment Center.
Children’s Mercy, in partnership with the University of Kansas Cancer Center, is a National Cancer Institute-designated pediatric cancer center. We provide advanced and innovative treatment for children with cancer, which results in survival rates that are frequently above national averages.
Our FACT-accredited Blood and Marrow Transplant (BMT) program connects with registries throughout the world to try to find a match for every child who needs a transplant. We have helped hundreds of children receive lifesaving blood and marrow transplants.
Research that leads to results
Historically, research for pediatric cancer and blood disorders has received less funding and attention than adult conditions. However, with renewed efforts by researchers and supporters, like the Big Slick celebrity fundraising events at Children’s Mercy, more and more children are receiving treatments tailored just for them.
Precision medicine
The hematology and oncology teams work closely with our experts in pediatric precision medicine, who work to pinpoint the most effective treatment for your child’s unique situation.
For instance, physician-researchers in the innovative GOLDILOKs program are seeking to find the “just right” dose of medication to treat the disease with the fewest possible side effects.
Clinical trials
We also offer access to clinical trials for new medications, including CAR-T immunotherapy, through the Experimental Therapeutics in Pediatric Cancer program. This type of translational research transforms lab work into new treatment options that are safe and effective for kids.
Stories
Ewing sarcoma: Annabelle's story
There's nothing better than helping a fierce competitor get back on the field. Learn how the Cancer Center at Children’s Mercy is treating Annabelle after she was diagnosed with localized Ewing sarcoma, a bone and soft tissue cancer.
Osteosarcoma: Lexy's Story
Lexy is a strong-willed five-year-old who loves art projects, tater tots, facility dog Jellybean and her big brother, Klay. Her fierce disposition has led the way during a challenging cancer diagnosis — and will continue to serve her well as a kid growing up with a limb difference.
Genomic Medicine Center: Finding answers for leukemia
Thanks to ground-breaking research at the Genomic Medicine Center at Children’s Mercy, new treatments provide hope to infants with acute lymphoblastic leukemia, a rare cancer of the blood and bone marrow that has a very poor prognosis. Watch as baby Brisia joins just 49 other infants around in the world in an oncology trial that pairs special drugs along with her standard chemotherapy in hopes of improving her chances for a cure.
Cancer Care Annual Report
Our 2022-2023 Cancer Care Annual Report focuses on brain tumors